What is Off-Label Use?

Off-label use describes the practice where a medical provider prescribes a medication for a purpose, dosage, patient group, or form of administration not specified in the drug’s FDA-approved labeling. While legal and relatively common in healthcare, this practice requires careful judgment by clinicians to ensure safety and efficacy.

In addiction and mental health treatment, off-label use often involves medications repurposed to manage symptoms like anxiety, insomnia, or cravings when no approved treatment exists. For instance, certain antidepressants may be used to alleviate withdrawal symptoms or reduce substance use, even though they aren’t FDA-approved for addiction.

Though off-label prescribing can offer valuable options when standard treatments fail, it also carries increased risks due to limited clinical testing in the new context. This underscores the importance of close monitoring and informed consent, particularly when treating vulnerable populations with complex psychiatric or substance use disorders.

Legally, off-label use is permissible in the U.S., but pharmaceutical companies are barred from marketing drugs for these non-approved purposes. Healthcare providers must rely on existing research, clinical experience, and professional guidelines when considering such prescriptions.